Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population (CAPABLE)

Viatris logo

Viatris

Status and phase

Completed
Phase 4

Conditions

Hypertension
Dyslipidemia

Treatments

Drug: Amlodipine/Atorvastatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00150384
A3841025

Details and patient eligibility

About

The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

African American men and women with concurrent hypertension and dyslipidemia that is either treated or untreated Subjects must satisfy the blood pressure and LDL-C inclusion criteria for their respective Cardiovascular Risk group determined at screening

Exclusion criteria

Subjects currently being treated with concomitant amlodipine and atorvastatin therapy, including Caduet Subjects with blood pressure at goal

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

106

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems